The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 18, issue 9, 2017

Economic evaluation of personalized medicine: a call for real-world data pp. 1065-1067

Robert Terkola, Fernando Antoñanzas and Maarten Postma

Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients pp. 1069-1078

Amaia Malet-Larrea, Estíbaliz Goyenechea, Miguel A. Gastelurrutia, Begoña Calvo, Victoria García-Cárdenas, Juan M. Cabases, Aránzazu Noain, Fernando Martínez-Martínez, Daniel Sabater-Hernández and Shalom I. Benrimoj

Out-migration and attrition of physicians and dentists before and after EU accession (2003 and 2011): the case of Hungary pp. 1079-1093

Júlia Varga

Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden pp. 1095-1105

Alessandra Ferrario

Preferences for public involvement in health service decisions: a comparison between best-worst scaling and trio-wise stated preference elicitation techniques pp. 1107-1123

Seda Erdem and Danny Campbell

Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data pp. 1125-1135

Katharina Bode, Rolf Vogel, Jochen Walker and Christoph Kröger

Improving risk equalization with constrained regression pp. 1137-1156

Richard C. Kleef, Thomas G. McGuire, René C. J. A. Vliet and Wynand P. P. M. de Ven

Gender-specific practice styles and ambulatory health care expenditures pp. 1157-1179

Boris Kaiser

A methodological proposal to evaluate the cost of duration moral hazard in workplace accident insurance pp. 1181-1198

Ángel Martín-Román and Alfonso Moral

Volume 18, issue 8, 2017

Market approval for drugs in the EU: time to change direction? pp. 933-936

Alessandro Curto, Katelijne de Vooren and Livio Garattini

The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies pp. 937-965

Alexandre Baptista, Inês Teixeira, Sónia Romano, António Vaz Carneiro and Julian Perelman

Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale pp. 967-977

Paul F. M. Krabbe, Elly A. Stolk, Nancy Devlin, Feng Xie, Elise H. Quik and A. Simon Pickard

Costs of dementia in the Czech Republic pp. 979-986

Iva Holmerová, Jakub Hort, Robert Rusina, Anders Wimo and Michal Šteffl

A method to simulate incentives for cost containment under various cost sharing designs: an application to a first-euro deductible and a doughnut hole pp. 987-1000

D. Cattel, R. C. Kleef and R. C. J. A. Vliet

Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies pp. 1001-1011

Hayley Bennett, Jason Gordon, Beverley Jones, Thomas Ward, Samantha Webster, Anupama Kalsekar, Yong Yuan, Michael Brenner and Phil McEwan

Junior doctors’ medical specialty and practice location choice: simulating policies to overcome regional inequalities pp. 1013-1030

Pedro Ramos, Hélio Alves, Paulo Guimaraes and Maria A. Ferreira

The impact of minimum wages on population health: evidence from 24 OECD countries pp. 1031-1039

Otto Lenhart

Cost effects of preterm birth: a comparison of health care costs associated with early preterm, late preterm, and full-term birth in the first 3 years after birth pp. 1041-1046

Josephine Jacob, Moritz Lehne, Andrea Mischker, Normen Klinger, Claudia Zickermann and Jochen Walker

Switching gains and health plan price elasticities: 20 years of managed competition reforms in The Netherlands pp. 1047-1064

Rudy Douven, Katalin Katona, Frederik Schut and Victoria Shestalova

Volume 18, issue 7, 2017

On vaccination programs in the EU Member States: the case of the human papilloma virus pp. 801-803

Reyes Lorente and Fernando Antonanzas

Healthier lifestyles after retirement in Europe? Evidence from SHARE pp. 805-830

Martina Celidoni and Vincenzo Rebba

Measuring customer preferences in the German statutory health insurance pp. 831-845

Jonas B. Pendzialek, Dusan Simic and Stephanie Stock

The social cost of chronic kidney disease in Italy pp. 847-858

Giuseppe Turchetti, S. Bellelli, M. Amato, S. Bianchi, P. Conti, A. Cupisti, V. Panichi, A. Rosati and F. Pizzarelli

Does drug price-regulation affect healthcare expenditures? pp. 859-867

Omer Ben-Aharon, Oren Shavit and Racheli Magnezi

Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort pp. 869-882

Dmitrij Achelrod, Jonas Schreyögg and Tom Stargardt

The social cost of drugs in France in 2010 pp. 883-892

Pierre Kopp and Marysia Ogrodnik

Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany pp. 893-904

Peter Greven, Vanja Sikirica, Yaozhu J. Chen, Tammy G. Curtice and Charles Makin

The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program pp. 905-919

Anne Neumann, Lars Lindholm, Margareta Norberg, Olaf Schoffer, Stefanie J. Klug and Fredrik Norström

Age effects in mortality risk valuation pp. 921-932

Raul Brey and Jose-Luis Pinto-Prades

Volume 18, issue 6, 2017

The enigma of value: in search of affordable and accessible health care pp. 667-670

Thomas D. Szucs, Martina Weiss and Guido Klaus

How important is severity for the evaluation of health services: new evidence using the relative social willingness to pay instrument pp. 671-683

Jeff Richardson, Angelo Iezzi and Aimee Maxwell

Evaluating the consequences of rheumatoid arthritis pp. 685-696

Björn Sossong, Stefan Felder, Malte Wolff and Klaus Krüger

A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precision pp. 697-701

Mark P. Connolly, Cole Tashjian, Nikolaos Kotsopoulos, Aomesh Bhatt and Maarten J. Postma

The costs of hazardous alcohol consumption in Germany pp. 703-713

Tobias Effertz, Frank Verheyen and Roland Linder

Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries pp. 715-730

Elena Nicod

Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients pp. 731-742

L. T. Burgers, W. K. Redekop, M. J. Al, S. K. Lhachimi, N. Armstrong, Simon Walker, C. Rothery, M. Westwood and J. L. Severens

The impact of the design of payment scales on the willingness to pay for health gains pp. 743-760

Lotte Soeteman, Job van Exel and Ana Bobinac

Annual direct and indirect costs attributable to nocturia in Germany, Sweden, and the UK pp. 761-771

Diana Weidlich, Fredrik L. Andersson, Matthias Oelke, Marcus John Drake, Aino Fianu Jonasson and Julian F. Guest

China’s medical savings accounts: an analysis of the price elasticity of demand for health care pp. 773-785

Hao Yu

Waist circumference, body mass index, and employment outcomes pp. 787-799

Jonas Minet Kinge

Volume 18, issue 5, 2017

Access, use, and challenges of claims data analyses in Germany pp. 533-536

Sarah Neubauer, Kristine Kreis, Mike Klora and Jan Zeidler

The impact of race, income, drug abuse and dependence on health insurance coverage among US adults pp. 537-546

Nianyang Wang and Xin Xie

Healthcare inequality issues among immigrant elders after neoliberal welfare reform: empirical findings from the United States pp. 547-565

Younsook Yeo

The dynamic relationship between health expenditure and economic growth: is the health-led growth hypothesis valid for Turkey? pp. 567-574

Emre Atilgan, Dilek Kilic and Hasan Ertugrul

Societal costs of fetal alcohol syndrome in Sweden pp. 575-585

Lisa Ericson, Lennart Magnusson and Bo Hovstadius

Measuring the efficiency of large pharmaceutical companies: an industry analysis pp. 587-608

Fernando Gascón, Jesús Lozano, Borja Ponte and David Fuente

Impact assessment of a pay-for-performance program on breast cancer screening in France using micro data pp. 609-621

Jonathan Sicsic and Carine Franc

Cost analysis of whole genome sequencing in German clinical practice pp. 623-633

Marika Plöthner, Martin Frank and J.-Matthias Graf Schulenburg

Measuring the productivity of residential long-term care in England: methods for quality adjustment and regional comparison pp. 635-647

Wei Yang, Julien Forder and Olena Nizalova

The effects of organized screening programs on the demand for mammography in Switzerland pp. 649-665

Mark Pletscher

Volume 18, issue 4, 2017

A perspective on the health care expenditures for defensive medicine pp. 399-404

Michael Osti and Johannes Steyrer

Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis pp. 405-415

Fredrik Salvesen Haukaas, Trude Margrete Arnesen, Brita Askeland Winje and Eline Aas

What happens to drinking when alcohol policy changes? A review of five natural experiments for alcohol taxes, prices, and availability pp. 417-434

Jon Nelson and Amy D. McNall

Out-of-pocket expenditures for pharmaceuticals: lessons from the Austrian household budget survey pp. 435-447

Alice Sanwald and Engelbert Theurl

Economic impact of patients admitted to stroke units in Spain pp. 449-458

Jose Alvarez-Sabín, Manuel Quintana, Jaime Masjuan, Juan Oliva, Javier Mar, Nuria Gonzalez-Rojas, Virginia Becerra, Covadonga Torres and María Yebenes

A comprehensive approach to assess the costs of renal replacement therapy for end-stage renal disease in France: the importance of age, diabetes status, and clinical events pp. 459-469

Anne-Line Couillerot-Peyrondet, Cléa Sambuc, Yoël Sainsaulieu, Cécile Couchoud and Isabelle Bongiovanni-Delarozière

Economies of scale: body mass index and costs of cardiac surgery in Ontario, Canada pp. 471-479

Ana P. Johnson, Joel L. Parlow, Brian Milne, Marlo Whitehead, Jianfeng Xu, Susan Rohland and Joelle B. Thorpe

Estimation of a physician practice cost function pp. 481-494

Lukas Kwietniewski, Mareike Heimeshoff and Jonas Schreyögg

Frequency and intensity of alcohol consumption: new evidence from Sweden pp. 495-517

Gawain Heckley, Johan Jarl and Ulf-G. Gerdtham

Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece pp. 519-531

John N. Yfantopoulos and Athanasios E. Chantzaras

Volume 18, issue 3, 2017

Disruptive innovation and EU health policy pp. 269-272

Bengt Jönsson

Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany pp. 273-292

Alexander Kuhlmann and J.-Matthias Graf Schulenburg

Primary health care utilisation and its costs among middle-aged smokers pp. 351-360

Jaana Keto, Hanna Ventola, Jari Jokelainen, Markku Timonen, Kari Linden, Tero Ylisaukko-oja, Sirkka Keinänen-Kiukaanniemi and Juha Auvinen

The impact of poor adult health on labor supply in the Russian Federation pp. 361-372

Yevgeniy Goryakin and Marc Suhrcke

The role of time and risk preferences in adherence to physician advice on health behavior change pp. 373-386

Marjon van der Pol, Deirdre Hennessy and Braden Manns

Analyzing disparity trends for health care insurance coverage among non-elderly adults in the US: evidence from the Behavioral Risk Factor Surveillance System, 1993–2009 pp. 387-398

Shireen Assaf, Stefano Campostrini, Cinzia Di Novi, Fang Xu and Carol Gotway Crawford

Volume 18, issue 2, 2017

Competition in the healthcare sector: a missing dimension pp. 135-138

Peter Zweifel

Competition in the Dutch hospital sector: an analysis of health care volume and cost pp. 139-153

Y. J. F. M. Krabbe-Alkemade, T. L. C. M. Groot and Maarten Lindeboom

Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment pp. 155-165

Axel C. Mühlbacher, John F. P. Bridges, Susanne Bethge, Ch.-Markos Dintsios, Anja Schwalm, Andreas Gerber-Grote and Matthias Nübling

How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence pp. 167-180

Wynand P. M. M. Ven, René C. J. A. Vliet and Richard C. Kleef

Four years of early benefit assessment of new drugs in Germany: a qualitative study on methodological requirements for quality of life data pp. 181-193

Christine Blome, Matthias Augustin, Hidayet Metin and David Lohrberg

Financial incentives, timing of births, and infant health: a closer look into the delivery room pp. 195-208

Hendrik Jürges

A voluntary deductible in health insurance: the more years you opt for it, the lower your premium? pp. 209-226

K. P. M. Winssen, R. C. Kleef and W. P. M. M. Ven

Assessing asthma severity based on claims data: a systematic review pp. 227-241

Christian Jacob, Jennifer S. Haas, Benno Bechtel, Peter Kardos and Sebastian Braun

The cost of frailty in France pp. 243-253

Nicolas Sirven and Thomas Rapp

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort pp. 255-267

Han-I. Wang, Alexandra Smith, Eline Aas, Eve Roman, Simon Crouch, Cathy Burton and Russell Patmore

Volume 18, issue 1, 2017

Priorities in the Polish health care system pp. 1-5

Sylwia Nieszporska

A short note on measuring subjective life expectancy: survival probabilities versus point estimates pp. 7-12

David R. Rappange, Job van Exel and Werner Brouwer

The impact of a sick pay waiting period on sick leave patterns pp. 13-31

Catherine Pollak

An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting pp. 33-47

L. B. Standfield, T. A. Comans and Paul Scuffham

Economic burden of toxicities associated with treating metastatic melanoma in eight countries pp. 49-58

Elizabeth Wehler, Zhongyun Zhao, S. Pinar Bilir, Julie Munakata and Beth Barber

Why trash don’t pass? pharmaceutical licensing and safety performance of drugs pp. 59-71

Tannista Banerjee and Arnab Nayak

Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study pp. 73-82

Tomáš Mlčoch, Jiří Klimeš, Libor Fila, Věra Vávrová, Veronika Skalická, Marek Turnovec, Veronika Krulišová, Jitka Jirčíková, Dana Zemková, Klára Vilimovská Dědečková, Alena Bílková, Vladimíra Frühaufová, Lukáš Homola, Zuzana Friedmannová, Radovan Drnek, Pavel Dřevínek, Tomáš Doležal and Milan Macek

Crisis, suicide and labour productivity losses in Spain pp. 83-96

Berta Rivera, Bruno Casal and Luis Currais

Competition and quality in a physiotherapy market with fixed prices pp. 97-117

Piia Pekola, Ismo Linnosmaa and Hennamari Mikkola

Medical ethics: enhanced or undermined by modes of payment? pp. 119-129

Peter Zweifel and Katharina Janus

Commentary to: Medical ethics: enhanced or undermined by modes of payment? pp. 131-132

Friedrich Breyer

Reply to commentary on: medical ethics: enhanced or undermined by modes of payment? pp. 133-134

Peter Zweifel and Katharina Janus